SUBSCRIBE
SUBSCRIBE
News   Drug Development

Sanofi Pasteur MSD’s Gardasil Gets 65% Subsidy in France

July 11, 2007 | 
1 min read
PARIS, July 11 (Reuters) - Sanofi Pasteur-MSD's cervical-cancer vaccine, Gardasil, will be 65 percent reimbursed in France for girls aged 14 to 23 years, the joint venture of drugmakers Sanofi-Aventis and Merck & Co. said on Wednesday.
Clinical research Postmarket research Europe
MORE ON THIS TOPIC
Close up shot of the dart arrow hit on bulleyes of dartboard to represent that the business reached the target with dark tone picture style. Target and goal as concept.
Diabetes
Lilly Tops Novo in Weight Loss Again, This Time on the Oral Front
February 26, 2026
 · 
2 min read
 · 
Annalee Armstrong
Working man icon pushing the load on the line. Hard work, labor, effort and determination concept.
HIV
Gilead, Merck Clear Path to Market for Daily HIV Pills With New Late-Stage Data
February 26, 2026
 · 
2 min read
 · 
Tristan Manalac
Alarm clock with pause sign, take a break, menopause concept, hormone replacement therapy
Regulatory
Patient Death Forces Partial Freeze on MacroGenics’ Gynecologic Cancer Study
February 25, 2026
 · 
2 min read
 · 
Tristan Manalac
Podcast
Lilly Bests Novo Again, Rare Disease Week Goes Regulatory, More CDC Leadership Upheaval
February 25, 2026
 · 
2 min read
 · 
Heather McKenzie